“…The AurA gene itself is revealed to be amplified in >50 and >12% of primary colorectal and breast tumors, respectively, as well as in prostate, colon, ovarian, and cervical tumor cells. − The translated protein has also been observed to overexpress, resulting in elevated kinase activity in several tumor types. , In cancerous cells, the AurA protein has been known to overexpress and localize mutually in the nucleus as well as in the cytoplasm, irrespective of their cell-cycle phases . The interactions between AurA and tumor suppressor p53 have frequently been linked to uncontrolled cell growth, while its inhibition through modulatory compounds has been postulated to trigger the activity of p53, which further leads to proliferation arrest and senescence in melanoma cells. − Overexpression of AurA has also been documented to increase genomic instability and aneuploidy by interrupting cell-cycle checkpoints while supporting cancer cell endurance and chemoresistance by activating the PI3K/Akt/GSK3 signaling cascade. ,, Hence, modulation of AurA activity has been deemed an essential approach to effective anticancer therapy.…”